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ABSTRACT 
The main aim of study is to evaluate the anti-arthritic effect of different extracts of Boerhaavia diffusa in arthritic rats. Different 
extracts were prepared by successive solvent extraction methods by using the various polar and non polar solvents and their % yields 
were calculated. Arthritis was induced by FCA induced arthritis model in rats and paw volume was measured on different days. 
Body weights of all animals were also measured simultaneously and at the end of experiment some haematological parameters were 
measured. On preliminary phytochemical studies extracts showed the presence of alkaloids, fatty acids, terpenoids, flavonoids and 
phenolic compounds. Among all extracts, methanolic extract significantly decreased the paw volume in all treated groups. 
Methanolic extracts also restored the body weight significantly. The results of our study revealed that all the extracts treated group’s 
causes significant alterations in the hematological parameters and maximal effects were observed at 400 mg/kg. Since methanolic 
extract showed best activity in arthritic model and its phytochemical study showed presence of flavonoids and phenolic compounds, 
so it may be possible that anti-arthritic activity of root extracts may be due to presence flavonoids.   
Keywords: Arthritis, FCA induced arthritis, Boerhaavia diffusa, haematological parameters, and Body weight 
 
Article Info: Received 12 Sep, 2018;   Review Completed  08 Oct 2018;   Accepted  10 Oct 2018;   Available online 15 Oct 2018 
Cite this article as:  
Parmar D, Jain NK, Tomar V, Anti-arthritic Evaluation of Different Extracts of Boerhaavia diffusa Linn. in FCA 
Induced Arthritis In Rats, Journal of Drug Delivery and Therapeutics. 2018; 8(5-s):388-393                                         
DOI: http://dx.doi.org/10.22270/jddt.v8i5-s.1922         
*Address for Correspondence:  
Deepika Parmar, PG Research Scholar, Department of Pharmacology, Oriental University, Indore (MP)-India 
 
 
INTRODUCTION 
Clinically, arthritis is characterized by Polyarthritic, 
swelling and, in many cases, manifests extra-articular 
involvement. In the early period of the disease, typical 
signs and symptoms are swelling and pain of the 
proximal interphalangeal and metacarpophalangeal 
joints. Later, the better joints become affected, 
especially those of the arms, feet and knees. In addition, 
arthritis can affect other systems of the body, and this 
may range from rheumatoid nodules to life-threatening 
vasculitis (Smolen & Steiner 2003).  
Presently many steroidal, NSAIDs and 
immunosuppressive drugs are used to change and 
manage inflammatory reaction and pain; however, they 
are connected with certain unwanted side effects (gastric 
ulceration, bleeding and platelets dysfunction) and due 
to a variety of toxic and adverse effects of synthetic 
drugs. With these difficulties, the ground of arthritis 
research has progressed exponentially with the use of 
herbal drugs (Flower et al., 1980).  
As per the literature review, it has been observed that 
Boerhaavia diffusa (root) are listed among the various 
medicinal plants widely been used in the acute and 
chronic inflammatory conditions. In the absence of any 
scientific confirmation for their anti-arthritic activity in 
chronic inflammatory conditions, an attempt is made for 
establishing the anti-arthritic activity of various extracts 
of roots of Boerhaavia diffusa so that we are able to 
come up with a more effective extract with fewer side 
effects in comparison with existing synthetic drugs.   
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MATERIALS AND METHODS 
Procurement of Plant Materials & Authentification 
The roots of Boerhaavia diffusa were purchased from 
the local market. The roots were taxonomically 
identified by Botanist and herbarium sheets were 
submitted in School of Studies in Botany, Vikram 
University, Ujjain under voucher specimen number 
SUI/2018. 
Preparation of Extract by Successive Solvent Method 
Accurately weighed quantity of roots of Boerhaavia 
diffusa were extracted using petroleum ether, 
chloroform, methanol and finally water by soxhlet 
apparatus for 72 h. The extracts were dried completely 
under reduced pressure.  After drying, the respective 
extracts were weighed and percentage yield was 
determined (Mukherjee, 2002). 
Preliminary Phytochemical Tests 
Qualitative chemical tests of ethanolic and Methanolic 
extracts were subjected to various chemical tests to 
detect various phytoconstituents (Kokate, 2003; 
Khandelwal, 2006). 
Preliminary In-Vivo Anti-Arthritic Activity 
Selection of animals  
Wistar albino rats of either sex between 2 and 3 months 
of age weighing 150-200 g were used which were 
procured from the central animal house of department of 
pharmacy, Oriental University, Indore. (MP), India. The 
animals were allowed free to access commercial rat 
pallet diet (Lipton India Ltd, Mumbai, India) and water 
ad libitum. The study designs were approved by the 
Institutional Animal Ethical Committee of department 
of pharmacy, Oriental University Indore. (MP), India.  
Acute toxicity studies 
The acute oral toxicity studies were carried out 
according to the guidelines set by the Organization for 
Economic Co-operation and Development (OECD), 
revised draft guideline 423 (OECD guidelines, 2001). 
Evaluation of anti-arthritic activity 
Suspensions of the test extracts were prepared in 1% 
Tween 80. 
The Wistar albino rats were divided into 11 groups of 
six animals in each. For the induction of chronic 
inflammatory response, FCA (0.1 ml) was injected in 
left ankle joint of rats on zero days. Prior to the injection 
of Freund’s Complete Adjuvant (FCA) measured by left 
paw volume of each animal at zero day for the induction 
of arthritis in Wistar rats. The treatment with all extracts 
were given once daily from day of injection to 21
st
 day.  
The animal groups are as follows (Arulmozhi et al., 
2011). 
Group-I: Normal control, treated with 1 ml of Tween 
80. 
Group-II: Arthritic control, treated with 0.1 mL of FCA 
on zero day. 
Group-III: Standard control: treated with prednisolone 
(10 mg/kg, p.o.) + FCA  
Group-IV: Treated with pet ether extracts of B. diffusa 
(200 mg/kg, p.o.) + FCA 
Group-V: Treated with pet ether extracts of B. diffusa 
(400 mg/kg, p.o.) + FCA 
Group-VI: Treated with chloroform extracts of B. 
diffusa (200 mg/kg, p.o.) + FCA 
Group-VII: Treated with chloroform extracts of B. 
diffusa (400 mg/kg, p.o.) + FCA 
Group-VIII: Treated with methanolic extracts of B. 
diffusa (200 mg/kg, p.o.) + FCA  
Group-IX: Treated with methanolic extracts of B. 
diffusa (400 mg/kg, p.o.) + FCA 
Group-X: Treated with aqueous extracts of B. diffusa 
(200 mg/kg, p.o.) + FCA 
Group-XI: Treated with aqueous extracts of B. diffusa 
(400 mg/kg, p.o.) + FCA 
Determination of various parameters 
Measurements of paw volume 
The strictness of adjuvant arthritis was quantified by 
measuring the volume of the hind paw using 
Plethysmograph. Paw volume (ml) was measured at 
zero days and afterward 4, 8, 12, 16 and 21 days of FCA 
post-inoculation. Data were uttered as the increase in 
paw volume with respects to day zero paw volume.  
The percentage inhibition of paw volume was calculated 
by following formula (Arulmozhi et al., 2011; 
Ignacimuthu et al., 2011). 
% inhibition=(Vc-Vt)/Vt×100 
Where,  
Vc-Paw volume of control animals 
Vt-Paw volume of treated animals 
Measurements of body weight 
Body weight was measured of all groups at zero days 
before immunization and at 21
st
 day after treatments 
over by means of a single pan weighing balance 
(Jalalpure et al., 2011). 
Measurements of hematological parameters  
On the 21
st
 day after arthritis initiation, rats were 
anaesthetized with ether and blood samples were 
collected into Ethylenediamine tetra-acetic acid 
(EDTA)-coated tubes from retro orbital junction. The 
number of leukocytes from each rat was determined 
using a counting chamber (celldyn-1200, Abbott 
Carepam). Erythrocyte sedimentation rate (ESR) was 
determined using the Wintrobe method. RBCs and 
Haemoglobin were determined by routine laboratory 
method (Jalalpure et al., 2011).  
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Statistical Analysis 
The values are expressed in mean ± SEM. The results 
were analyzed by using one way analysis of variance 
(ANOVA) followed by Dunnet’s "t” test to determine 
the statistical significance. p< 0.05 was chosen as the 
level of significance.  
RESULTS 
Extractive Value Determination 
Dried roots of Boerhaavia diffusa were extracted by 
various solvents i.e. petroleum ether, chloroform, 
methanol and finally water. The percentage yields of all 
dried extracts were as follows. 
  
Table 1: Different extracts with their appearance and % yield (in gm) 
S. No. Extracts Color of dried extracts Consistency of 
dried extracts 
% Yield 
(W/W) 
1 Petroleum ether extract of Boerhaavia diffusa Dark Brown Sticky 12 % 
2 Chloroform extract of Boerhaavia diffusa Dark Brown Dried powder 7 % 
3 Methanolic extract of Boerhaavia diffusa Dark Reddish & Orange  Sticky 18 % 
4 Aqueous extract of Boerhaavia diffusa Light Brown  Sticky 5.5 % 
 
Preliminary Phytochemical Screening 
Presence of carbohydrates, proteins, amino acids, fat, 
oils, steroids, terpenoids, glycosides, alkaloids, tannins 
and other phenolics compounds were confirmed on 
preliminary phytochemical studies. 
Anti-Arthritic Activity of Different Root Extracts 
Freund’s complete adjuvant induced rat paw edema 
Paw volume were recorded on 4
th
, 8
th
, 12
th
, 16
th
, 21
st
 day 
after injection of FCA/CFA. The CFA-induced arthritic 
control group showed signs of arthritis development, as 
seen by the increase in the paw volume and other 
indications, such as decreased body weight, also showed 
induction of arthritis in the CFA-treated control group 
rats. The assessment made on the 21
st
 day showed that 
the treatment of Boerhaavia diffusa at both doses (low 
and high) had moderately significant and highly 
significant effect and reduced (p< 0.01& p<0.001) the 
adjuvant-induced lesions in the respective treatment 
groups as compared with the arthritis control group. The 
results were expressed in Figure No 1 & 2. 
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Figure 1: Effect of pet. ether & chloroform extracts on paw volume in arthritic rats 
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Figure 2: Effect of methanolic & aqueous extracts on paw volume in arthritic rats 
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Effects on body weight 
Although the body weight always declined in arthritic 
control group from 14
th
 day to 21
st
 day. In arthritic 
group, decrease in body weight was observed on the 
subsequent days, whereas groups treated with standard 
and extracts of Boerhaavia diffusa showed 
improvements in body weight. This effect was observed 
from 14
th
 day to last day of the experiment as compared 
to arthritic rats. All the extracts had moderately and 
highly significant increase in body weight (p<0.01 & 
p<0.001) as compared to arthritic rats, but highly 
significant effect was observed in methanolic extract. 
   
Table 2: Effects of root extracts on body weight in FCA induced arthritis in rat 
S. No. Groups & Treatments Days 
Zero 21
st
 
1 Normal Control 190.20±3.18 191.47±0.20 
2 Arthritic Control, 1% Tween 80, p.o. 191.40±3.38 160.18±3.24*** 
3 Prednisolone, 10 mg/kg, p.o. 191.80±4.10 210.30±3.12*** 
4 Pet. ether, 200 mg/kg, p.o. 191.18±3.40 168.20±3.16 
5 Pet. ether, 400 mg/kg, p.o. 190.20±3.50 175.40±2.78* 
6 Chloroform, 200 mg/kg, p.o. 190.18±3.12 170.40±3.91 
7 Chloroform, 400 mg/kg, p.o. 192.25±1.40 180.60±3.12* 
8 Methanolic, 200 mg/kg, p.o. 191.10±2.65 205.35±3.38** 
9 Methanolic, 400 mg/kg, p.o. 190.50±2.20 211.63±2.56** 
10 Aqueous, 200 mg/kg, p.o. 190.65±2.38 181.44±4.19* 
11 Aqueous, 400 mg/kg, p.o. 192.30±1.18 185.81±1.14* 
Values are expressed as mean±SEM, n=6 in each group; *p<0.05, compared to disease control ** p<0.01, compared to disease 
control. ***p<0.001, compared to disease control 
Effects on haematological parameters 
Arthritis also affects the various haematological 
parameters i.e. WBCs, RBCs, ESR and Hb. It was found 
in arthritic rat that on 21
st
 day, elevation in the total 
WBC counts and reduction in RBC. However, 
significantly (p<0.001) increased ESR while the 
haemoglobin was significantly (p<0.001) reduced in the 
control group when compared with normal group. 
However, standard and Boerhaavia diffusa had highly 
significant effects (p<0.001) in recovery of RBCs and 
haemoglobin. They also showed highly significant 
effects on decrease in WBCs and ESR. Among all the 
extracts, methanolic extract had highly significant effect 
on haematological parameters. 
  
Table 3: Effects of root extract on haematological parameters in arthritis in rat 
S. 
No. 
Groups & Treatments Haematological Parameters 
Total WBCs 
count×10
3
 cells/mm
3
 
RBCs 
(Million/mm)
2
 
Haemoglobin 
(g/dl) 
ESR (mm/h) 
1 Normal Control,  
1% Tween 80, p.o. 
8.45±0.90 8.88±1.11 15.82±2.33 10.40±2.42 
2 Arthritic Control,  
1% Tween 80, p.o. 
15.34±1.22*** 5.23±1.16** 9.46±2.12** 15.83±2.18*** 
3 Prednisolone 
10 mg/kg, p.o. 
8.66±1.75*** 8.10±1.28** 14.24±2.46*** 11.90±2.12*** 
4 Pet. ether,  
200 mg/kg, p.o. 
14.18±1.16   5.24±1.18 9.78±2.16 14.40±2.16 
5 Pet. ether, 
400 mg/kg, p.o. 
14.26±1.31 5.96±1.24 9.48±2.38 14.10±2.19 
6 Chloroform, 
200 mg/kg, p.o. 
11.38±2.26 6.44±1.09 10.32±2.31 13.85±2.10 
7 Chloroform, 
400 mg/kg, p.o. 
10.86±2.21* 6.58±1.19 11.64±2.82 13.12±2.32 
8 Methanolic, 
200 mg/kg, p.o. 
10.18±1.16** 7.24±1.18** 12.78±2.55** 12.49±2.16** 
9 Methanolic, 
400 mg/kg, p.o. 
8.46±1.31*** 8.96±1.24*** 14.48±2.89*** 11.56±2.19*** 
10 Aqueous, 
200 mg/kg, p.o. 
14.10±2.12 5.72±1.36 11.31±2.21* 13.89±2.26 
11 Aqueous, 
400 mg/kg, p.o. 
13.52±2.51 5.84±1.57 12.65±2.34* 13.14±2.14 
Values are expressed as mean±SEM, n=6 in each group; *p<0.05, compared to disease control ** p<0.01, compared to disease 
control. ***p<0.001, compared to disease control 
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DISCUSSION 
CFA-induced experimental model for arthritis is well 
thought-out neighboring to simulating human 
rheumatoid arthritis and therefore it is the most widely 
used chronic test model in which the linked clinical and 
Histopathological changes are comparable to those seen 
in human form (Billingham & Davies, 1979; Butler et 
al., 1992). In this model, dead tubercle bacilli in liquid 
paraffin initiate an immune-mediated inflammatory 
reaction which ultimately culminates in chronic 
inflammation (Cai et al., 2006). Initially the injection of 
CFA into the right hind-foot produces an inflamed 
swelling in the paw which reaches to its maximum 
during the first 3 days. After the 13
th
 day additional 
swelling of the feet or joints occurs and by the 21
st
 day 
the inflammation starts to subside leaving pale 
granulomatous swellings around the joints (Newbould et 
al., 1963).  
Treatment with all test extracts of roots showed dose 
dependent suppression in edema of the injected paw 
(primary lesions). Maximal effects were observed at the 
dose of 400 mg/kg body weight of test extracts. 
(Pearson & Wood, 1963). Our study results reveal that 
extracts of Boerhaavia diffusa treated rats significantly 
reduced the paw volume as compared to control 
animals.  
During the expansion of arthritic syndrome, the body 
weight of rats used as a meandering index in restitution 
of health. The body weight was significantly decreased 
in arthritic rat as compared to normal rat, but in the test 
extracts and standard drug treated groups, the body 
weights of the rats did not decline. (Winder et al., 1969).  
In our study, the body weight was significantly 
increased in the groups treated with prednisolone and all 
the extracts treated groups and this may be due to the 
restitution of absorption capacity of intestine.  
With the development of arthritic conditions, there was 
a significant change in haematological parameters i.e. 
red blood cells (RBCs), white blood cells (WBCs), 
Haemoglobin (Hb) and erythrocyte sedimentation rate 
(ESR). As the disease progressed, RBCs and 
haemoglobin were decreased while; WBCs and ESR 
were increased in arthritic control group.  
It was planned that the reduction in the Hb and RBC 
count during arthritis results from premature destruction 
of red blood cells, reduced erythropoietin levels (Mowat 
et al., 1971). Further information of a significant rise of 
WBC count, in arthritic control group is possibly due to 
the stimulation of immune system. In addition an 
increase in ESR is a common feature in rheumatoid 
arthritis (Glenn et al.,1971) and this increase in the ESR 
is attributed to the accelerated formation of endogenous 
proteins (Hu et al., 2005).  
The results of our study revealed that all the extracts 
treated group’s causes significant alterations in the 
hematological parameters and maximal effects were 
observed at 400 mg/kg.  
Since methanolic extract showed best activity in arthritic 
model and its phytochemical study showed presence of 
flavonoids and phenolic compounds, so it may be 
possible that anti-arthritic activity of root extracts may 
be due to presence flavonoids.   
CONCLUSION 
This study was designed to evaluate the anti-arthritic 
activity of various extracts of Boerhaavia diffusa in 
suitable arthritic models in rats.  
In conclusion, the mechanism may be mediated via the 
hang-up of prostaglandin synthesis in acute 
inflammatory reaction as well as reserve of various 
lysosomal enzymes in chronic inflammatory responses 
this, justifies the claim made by Siddha and Ayurveda. 
Flavonoids present in methanolic extract could serve as 
lead molecules for development of prospective anti-
arthritic agents. 
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